Oxford Nanopore Technologies

IPO

Oxford Nanopore Technologies is a biotech company in London, United Kingdom, founded in 2005. It has raised $1.6B across 25 rounds, most recently a $140.0M Venture Round in 2024 (est.).

To enable the analysis of anything, by anyone, anywhere.

Headquarters
London
Employees
1001–5000
Founded
2005
Business Model
B2B
Total Funding
$1.6B
Last Round
$140.0M Venture RoundJan 2024
Rounds
25
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 25 funding rounds and 16 investors for this company. The full record is or through the API.

About

Oxford Nanopore Technologies, founded in 2005 as a University of Oxford spin-out, develops a novel generation of DNA and RNA sequencing technology. Its devices — from pocket-sized MinION to high-throughput PromethION — enable real-time, long-read sequencing in any environment. The company, listed on the London Stock Exchange (ONT), employs over 1,300 staff and sells to more than 120 countries across research, clinical, and applied markets.

Summary

It lists 1001–5000 employees. It has raised $1.6B in total across 25 rounds, most recently a $140.0M Venture Round in 2024 (est.). Investors include IP Group, Illumina Ventures and bioMérieux.

Tech & App Stack

9 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Venture RoundVenture Round2024 (est.)
$140.0M

Sign up to see all 26 events

Funding: Seed through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Oxford Nanopore Technologies on Indexed.vc
<a href="https://indexed.vc/companies/oxford-nanopore-technologies"><img src="https://indexed.vc/api/badge/company/oxford-nanopore-technologies" alt="Oxford Nanopore Technologies on Indexed.vc" width="260" height="76" /></a>